60 Participants Needed

Mobility Promotion for Cardiovascular Disease

MW
SA
Overseen ByShirko Ahmadi, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Université de Sherbrooke
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Mobility promotion for cardiovascular disease?

Research shows that cardiac rehabilitation, which includes mobility promotion, significantly benefits patients with cardiovascular disease by improving physical capacity, quality of life, and reducing the risk of future heart events.12345

Is mobility promotion generally safe for humans?

Research on physical activity interventions, including mobility promotion, shows that while minor injuries like muscle strains can occur, serious adverse events are rare. Studies recommend starting with low intensity and gradually increasing to ensure safety.678910

How does the mobility promotion treatment for cardiovascular disease differ from other treatments?

The mobility promotion treatment for cardiovascular disease is unique because it focuses on increasing physical activity as a way to improve heart health, rather than relying on medication. This approach emphasizes the benefits of simply moving more, which can lead to better health outcomes even with modest increases in activity.1112131415

What is the purpose of this trial?

Frailty describes the overall health of a person. Inpatients with cardiovascular problems have a higher risk for frailty - or the sick are more likely to get sicker - causing longer hospital stays, hospital readmission, and death. Females are particularly vulnerable to these problems, generally displaying higher frailty levels than males. In hospital, patients spend almost all their time in bed, and this lack of movement worsens cardiovascular and musculoskeletal health, sometimes lengthening patients' hospital stay and priming them for another cardiovascular event. Prolonged sedentary time may be more detrimental on frailty among females than males. The proposed pilot project will test if an in-hospital General Medicine mobilization program reduces frailty (measure of overall health) in male and female inpatients with cardiovascular disease. A Kinesiologist will provide daily check-ins and promote daily movement (e.g., standing more, resistance bands, physical activity promotion, etc.). The investigators expect both males and females will lower their frailty levels, but given their higher frailty levels in general and because females are typically less active than males, the investigators expect the intervention's effects to be greatest among females. Sixty patients (30 females) will be recruited. Patients with a major heart problem, projected to be in-hospital for at least 3-days, and can independently provide consent. Frailty will be measured using a validated questionnaire. Participants will also be equipped with activity monitors for 24h/d continuous wear to measure amount of time spent stepping, sitting, and lying. Hospital records will be used for length of stay and readmissions. The investigators will compare the outcomes (activity and frailty) between males and females to determine if the intervention impacted each sex differently. This work will guide improved care plans to decrease frailty and improve health outcomes in both male and female patients with heart problems.

Eligibility Criteria

This trial is for male and female inpatients with cardiovascular disease who are at risk of frailty. Participants must have a major heart problem, be expected to stay in the hospital for at least 3 days, and be able to give consent independently. The study aims to include 60 patients (30 females).

Inclusion Criteria

Patients who are admitted to unit 4C at the Vitalité Health Network
Patients who are projected to be in-hospital for at least 3 days
Patients who are not in a shared room with another study participant
See 3 more

Exclusion Criteria

Patients enrolled in other clinical trials or interventions that might confound the results of the study

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Treatment

Participants receive a mobilization program with daily check-ins by a Kinesiologist to promote movement and reduce frailty

2 weeks
Daily visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Mobility promotion
Trial Overview The trial tests a mobilization program led by a Kinesiologist involving daily movement activities like standing, using resistance bands, and promoting physical activity. It aims to reduce frailty levels among these patients, with an expectation that it may benefit females more due to their generally higher levels of frailty.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: MalesExperimental Treatment1 Intervention
A team of Kinesiologists visit the patients daily from admission to discharge to promote movement and help them mobilize to the best of their capabilities (e.g., walking, standing, or sitting on the edge of the bed).
Group II: FemalesExperimental Treatment1 Intervention
A team of Kinesiologists visit the patients daily from admission to discharge to promote movement and help them mobilize to the best of their capabilities (e.g., walking, standing, or sitting on the edge of the bed).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Université de Sherbrooke

Lead Sponsor

Trials
317
Recruited
79,300+

Vitalite Health Network

Collaborator

Trials
3
Recruited
130+

Findings from Research

Cardiac rehabilitation programs have been updated to include coronary risk factor reduction, which is crucial for patients with established cardiovascular disease to lower their risk of future heart attacks, strokes, and death.
These modernized rehabilitation programs have been shown to significantly improve health outcomes for both men and women with coronary heart disease, enhancing their long-term well-being.
Modern cardiac rehabilitation: Integrating the best measures to reduce a second cardiac event.Armbruster, RA., Lim, MJ.[2021]
Cardiac rehabilitation has been proven to significantly improve health outcomes for patients with cardiovascular disease, yet less than 50% of eligible patients participate in these programs.
To increase participation, a collaborative approach involving multiple agencies and professionals is necessary, along with tailored programs that address individual patient needs to enhance adherence and effectiveness.
Improving wellbeing with cardiac rehabilitation.Edmunds, L.[2016]
Comprehensive risk factor interventions, including regular physical activity, significantly improve outcomes for patients with cardiovascular disease (CVD), enhancing physical work capacity and overall survival while reducing the need for invasive procedures.
These interventions are beneficial not only for patients with coronary artery disease (CAD) but also for those with other atherosclerotic conditions, as they share common risk factors and can lead to improved quality of life and reduced cardiovascular events.
Reducing the risk of heart disease and stroke.Franklin, BA., Sanders, W.[2010]

References

Modern cardiac rehabilitation: Integrating the best measures to reduce a second cardiac event. [2021]
Improving wellbeing with cardiac rehabilitation. [2016]
Reducing the risk of heart disease and stroke. [2010]
Telemonitored exercise-based cardiac rehabilitation improves physical capacity and health-related quality of life. [2020]
Patients who do not complete cardiac rehabilitation have an increased risk of cardiovascular events during long-term follow-up. [2020]
The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology. [2018]
Adverse events among high-risk participants in a home-based walking study: a descriptive study. [2022]
Screening, safety, and adverse events in physical activity interventions: collaborative experiences from the behavior change consortium. [2022]
Patient education interventions to improve physical activity in patients with intermittent claudication: a protocol for a systematic mixed-studies review. [2022]
Walking for prevention of cardiovascular disease in men and women: a systematic review of observational studies. [2021]
11.United Statespubmed.ncbi.nlm.nih.gov
The impact of moving more, physical activity, and cardiorespiratory fitness: Why we should strive to measure and improve fitness. [2021]
Movement as Medicine for Cardiovascular Disease Prevention: Pilot Feasibility Study of a Physical Activity Promotion Intervention for At-Risk Patients in Primary Care. [2022]
Behaviour change techniques in cardiovascular disease smartphone apps to improve physical activity and sedentary behaviour: Systematic review and meta-regression. [2022]
Meta-analysis of interventions to increase physical activity among cardiac subjects. [2021]
Physiotherapy-Led Health Promotion Strategies for People with or at Risk of Cardiovascular Diseases: A Scoping Review. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security